Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer
- PMID: 11123353
- DOI: 10.4049/jimmunol.166.1.678
Increased production of immature myeloid cells in cancer patients: a mechanism of immunosuppression in cancer
Abstract
Defective dendritic cell (DC) function caused by abnormal differentiation of these cells is an important mechanism of tumor escape from immune system control. Previously, we have demonstrated that the number and function of DC were dramatically reduced in cancer patients. This effect was closely associated with accumulation of immature cells (ImC) in peripheral blood. In this study, we investigated the nature and functional role of those ImC. Using flow cytometry, electron microscopy, colony formation assays, and cell differentiation in the presence of different cell growth factors, we have determined that the population of ImC is composed of a small percentage (<2%) of hemopoietic progenitor cells, with all other cells being represented by MHC class I-positive myeloid cells. About one-third of ImC were immature macrophages and DC, and the remaining cells were immature myeloid cells at earlier stages of differentiation. These cells were differentiated into mature DC in the presence of 1 microM all-trans-retinoic acid. Removal of ImC from DC fractions completely restored the ability of the DC to stimulate allogeneic T cells. In two different experimental systems ImC inhibited Ag-specific T cell responses. Thus, immature myeloid cells generated in large numbers in cancer patients are able to directly inhibit Ag-specific T cell responses. This may represent a new mechanism of immune suppression in cancer and may suggest a new approach to cancer treatment.
Similar articles
-
All-trans-retinoic acid improves differentiation of myeloid cells and immune response in cancer patients.Cancer Res. 2006 Sep 15;66(18):9299-307. doi: 10.1158/0008-5472.CAN-06-1690. Cancer Res. 2006. PMID: 16982775 Free PMC article. Clinical Trial.
-
All-trans-retinoic acid eliminates immature myeloid cells from tumor-bearing mice and improves the effect of vaccination.Cancer Res. 2003 Aug 1;63(15):4441-9. Cancer Res. 2003. PMID: 12907617
-
Antigen-specific inhibition of CD8+ T cell response by immature myeloid cells in cancer is mediated by reactive oxygen species.J Immunol. 2004 Jan 15;172(2):989-99. doi: 10.4049/jimmunol.172.2.989. J Immunol. 2004. PMID: 14707072
-
Immature myeloid cells and cancer-associated immune suppression.Cancer Immunol Immunother. 2002 Aug;51(6):293-8. doi: 10.1007/s00262-002-0280-8. Epub 2002 Apr 24. Cancer Immunol Immunother. 2002. PMID: 12111117 Free PMC article. Review.
-
Dendritic Cells in the Context of Human Tumors: Biology and Experimental Tools.Int Rev Immunol. 2016;35(2):116-35. doi: 10.3109/08830185.2015.1096935. Int Rev Immunol. 2016. PMID: 27007190 Review.
Cited by
-
Melanoma-derived factors alter the maturation and activation of differentiated tissue-resident dendritic cells.Immunol Cell Biol. 2016 Jan;94(1):24-38. doi: 10.1038/icb.2015.58. Epub 2015 May 26. Immunol Cell Biol. 2016. PMID: 26010746
-
Increased CD14(+)HLA-DR (-/low) myeloid-derived suppressor cells correlate with extrathoracic metastasis and poor response to chemotherapy in non-small cell lung cancer patients.Cancer Immunol Immunother. 2013 Sep;62(9):1439-51. doi: 10.1007/s00262-013-1450-6. Epub 2013 Jun 13. Cancer Immunol Immunother. 2013. PMID: 23760662 Free PMC article. Clinical Trial.
-
Neutrophils Suppress Intraluminal NK Cell-Mediated Tumor Cell Clearance and Enhance Extravasation of Disseminated Carcinoma Cells.Cancer Discov. 2016 Jun;6(6):630-49. doi: 10.1158/2159-8290.CD-15-1157. Epub 2016 Apr 12. Cancer Discov. 2016. PMID: 27072748 Free PMC article.
-
Pancreatic ductal adenocarcinoma: a review of immunologic aspects.J Investig Med. 2012 Apr;60(4):643-63. doi: 10.2310/JIM.0b013e31824a4d79. J Investig Med. 2012. PMID: 22406516 Free PMC article. Review.
-
Phenotypic, morphological, and functional heterogeneity of splenic immature myeloid cells in the host response to tularemia.Infect Immun. 2012 Jul;80(7):2371-81. doi: 10.1128/IAI.00365-12. Epub 2012 Apr 23. Infect Immun. 2012. PMID: 22526678 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials